Sep 12 |
Kazia Therapeutics enters into licensing agreement with QIMR Berghofer
|
Sep 12 |
KAZIA EXECUTES LICENSING AGREEMENT WITH QIMR BERGHOFER
|
Jul 25 |
Biotech Stock Laboratory: Try a Small Experiment With Kazia Therapeutics
|
Jul 12 |
Kazia Therapeutics (KZIA) Soars 490% in a Week: Here's Why
|
Jul 12 |
From Pennies to Dollars: 3 Sub-$5 Stocks Set to Explode Higher
|
Jul 11 |
Kazia Therapeutics stocks soar following Phase II/III win
|
Jul 10 |
Why SeaStar Medical Holding Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
|
Jul 10 |
Kazia stock soars 142% on study results for brain cancer therapy
|
Jul 10 |
Kazia Therapeutics Announces Phase II/III Clinical Trial Results for Paxalisib in Glioblastoma
|
May 1 |
KAZIA REPORTS SUCCESSFUL STAGE 1 COMPLETION OF THE EVT801 PHASE 1 CLINICAL TRIAL IN ADVANCED CANCER PATIENTS
|